about
sameAs
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionAntisense inhibition of BCL-2 expression induces retinoic acid-mediated cell death during differentiation of human NT2N neurons.Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case reportAmyloid and tau cerebrospinal fluid biomarkers in HIV infection.Irreversible effects of dichloromethane on the brain after long term exposure: a quantitative study of DNA and the glial cell marker proteins S-100 and GFA.Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous systemPatients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementiaCerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.Cerebrospinal fluid biomarkers in cardiac arrest survivors.Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathyCerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older womenDefining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.Bcl-2 expression regulates cell sensitivity to S100beta-mediated apoptosis.CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients.Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years.CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.No neurochemical evidence for brain injury caused by heading in soccer.Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.Long term neurotoxicity of styrene. A quantitative study of glial fibrillary acidic protein (GFA) and S-100.Chlorpromazine treatment of blood-brain barrier dysfunction. A quantitative and fluorescence microscopical study on small cerebral stab wounds in the rat.Soluble protein and peptide pattern from different regions of rat brain during pre- and early postnatal development.Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.Elevated neurofilament levels in neurological diseases.Immunocytochemical localisation of caligulin-like immunoreactivity in rat tissues.Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.Immunologic and neurobiologic characteristics support that interstitial cystitis is a heterogeneous syndrome.The S-100 protein in cerebrospinal fluid: a simple ELISA method.Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis.
P50
Q24810504-9B197E99-1E8D-464A-8317-3E9578257499Q31961983-168D79BA-ACED-48D1-BD9B-F740CFB6EAEEQ33257724-2C60C826-2C42-4286-B847-02CF0E64DEBAQ33520347-91DD30F7-79C6-436C-9B3B-94C74B3604D5Q33572098-0F1CE0E3-94F7-4EC4-80CC-5FCDB1EAC209Q33629765-B75559FE-BD5D-41C6-AFCD-0131B08CED2DQ33803161-0CAF2E0C-B55E-4D70-8BDC-AC249ABFEA31Q33867672-37668712-A1D2-4D94-94D4-F33D7E355508Q34380942-7C054DA0-C2D3-4482-922C-DE43DE74DD94Q34402201-562AB83A-554F-465C-BB17-2C8A6037DA7CQ34746995-CBD073DB-DBC6-4470-92A8-840476528E2EQ35008855-4446969D-DDBF-4DC4-8BA5-9056B4E01998Q35042974-AD13B1E5-65C1-4929-878D-2BD4AACE1402Q35093695-433CC49A-F8B2-447F-B004-DD114BBD466EQ35458189-0974CEFF-1728-4B86-B7A3-EFEAACF1CCC9Q36227420-08A7CB2F-815E-4FE5-AF34-79A886C8325FQ37015519-2D6D5CFF-6411-4805-A927-4801F949B03BQ37194137-214AF99B-2ABA-47B6-A5EA-22D292426823Q38323439-A9639554-069C-485A-BBF1-6C8E45594A53Q38433078-630A8565-B734-4DBF-90FB-9D7863BAA47CQ39170054-1A4CD2F1-F8A6-45A5-9B5C-5F2425011885Q39187085-C6272A95-6BEE-415A-8CB9-DC3E01E7435EQ39435668-7B4BFC6D-5407-4AB8-8718-4F88BF073BA2Q39469698-910ED4CD-BA1A-4D48-9BDB-6D09819E6D1BQ39713596-269CECCD-D5DC-4BEF-B39A-0C1E2427EEDDQ40047133-5250F8C2-3D67-4DB1-8A38-8A986E875C82Q40302692-F71721FF-9EE6-4969-96AD-491F67A9BA4FQ40653834-A2AB5F27-6ACB-4F3A-BBA1-02F1A1A0087AQ40864697-C7D8F44C-4054-4657-9B94-DD39B1B3D03DQ41463900-847C0DE1-8A9B-4418-AFED-F76B4958A480Q41659059-0736D9CD-2962-43C9-8CE4-4AB5615A1490Q41745328-A718B5D7-8CAA-46FF-9D92-EEFAC33405B5Q41907099-84387233-817B-4721-A24E-A34E2222556BQ42450342-074B3A98-3BD4-412B-9990-65B3188EA7FEQ42525534-B46B952E-95CC-4553-A40D-E25582B2F4B7Q43027774-DD8D9A24-D1AD-4906-AE98-DE2DAB322DA9Q43621304-AFDD6317-0942-410A-AA1D-05C1022359C2Q43695276-1864EECA-9A91-4381-839D-3117B4986DA6Q43752194-5DC66FA9-2BDC-4195-A42D-CB4CD949DA08Q44020668-6623CCF6-44BB-4095-B2E1-DAE0CBBBB413
P50
description
Zweeds onderzoeker
@nl
forsker
@nb
researcher
@en
հետազոտող
@hy
name
Lars E. Rosengren
@da
Lars E. Rosengren
@de
Lars E. Rosengren
@fr
Lars E. Rosengren
@nb
Lars E. Rosengren
@nn
Lars E. Rosengren
@sv
Lars Rosengren
@ast
Lars Rosengren
@en
Lars Rosengren
@es
Lars Rosengren
@nl
type
label
Lars E. Rosengren
@da
Lars E. Rosengren
@de
Lars E. Rosengren
@fr
Lars E. Rosengren
@nb
Lars E. Rosengren
@nn
Lars E. Rosengren
@sv
Lars Rosengren
@ast
Lars Rosengren
@en
Lars Rosengren
@es
Lars Rosengren
@nl
altLabel
Lars E. Rosengren
@en
Rosengren L
@ast
Rosengren L
@es
Rosengren L
@nl
prefLabel
Lars E. Rosengren
@da
Lars E. Rosengren
@de
Lars E. Rosengren
@fr
Lars E. Rosengren
@nb
Lars E. Rosengren
@nn
Lars E. Rosengren
@sv
Lars Rosengren
@ast
Lars Rosengren
@en
Lars Rosengren
@es
Lars Rosengren
@nl
P106
P21
P27
P31
P4012
P496
0000-0003-0505-8896